| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 01/11/2005 | US6841162 Cosmetic or dermatological composition contacting at least one natural or recombinant spider silk or an analog |
| 01/11/2005 | US6841158 Chicken embryo lethal orphan or fowl adenovirus type 1 genome contains a deletion consisting essentially of nucleotides 41,731-43,684 of the wild type |
| 01/11/2005 | US6841157 Wherein early genes are from a first type of papillomavirus and the late genes are from a second papillomavirus |
| 01/11/2005 | US6841156 Treating cholinergic controlled secretions including excessive sweating, lacrimation and mucus secretion; relieving pain associated with smooth muscle disorders, including spasms in the sphincter muscles; type A & B toxins |
| 01/11/2005 | US6841155 Immunization against and treatment for infection by H. pylori |
| 01/11/2005 | US6841154 Cross-reactive monoclonal and polyclonal antibodies which recognize surface proteins from coagulase-negative staphylococci and Staphylococcus aureus |
| 01/11/2005 | US6841147 Stem cell factor compositions |
| 01/11/2005 | US6841145 CeSERT genes, proteins, and modulatory compounds |
| 01/11/2005 | CA2342072C Kunitz domain polypeptide zkun6 |
| 01/11/2005 | CA2337088C Methods and constructs for protein expression |
| 01/11/2005 | CA2267670C Method for preparing human stem cell factor polypeptide |
| 01/11/2005 | CA2169631C A novel homeobox factor which stimulates insulin expression in pancreatic islet cells |
| 01/11/2005 | CA2128711C Trypsin inhibitors |
| 01/11/2005 | CA2088343C Stable fibrinogen solution |
| 01/11/2005 | CA2033175C Self-assembled, defective, non-self-propagating viral particles |
| 01/11/2005 | CA1341472C Process for altering the host range of bacillus thuringiensis toxins, and novel toxins produced thereby |
| 01/07/2005 | CA2434995A1 Oncolytic viruses for the treatment of neoplasms having activated pp2a or rac |
| 01/06/2005 | WO2005001486A1 Modulating the interaction between hgf beta chain and c-met |
| 01/06/2005 | WO2005001417A2 Crystals of hepatitis c virus polymerase and/or hepatitis c virus polymerase-like proteins and the use thereof |
| 01/06/2005 | WO2005001131A2 Methods for diagnosing mood disorders |
| 01/06/2005 | WO2005001116A1 Utilization of cell forcibly expressing toll-like receptor |
| 01/06/2005 | WO2005001107A1 Method of separating optical isomers of a protected aminoacid |
| 01/06/2005 | WO2005001106A1 Polypeptide mixture of high glutamine/glutaminic acid content and process for producing the same |
| 01/06/2005 | WO2005001103A2 Methods of generating chimeric adenoviruses and uses for such chimeric adenoviruses |
| 01/06/2005 | WO2005001099A2 Protein expression system |
| 01/06/2005 | WO2005001096A1 Vaccines against sars |
| 01/06/2005 | WO2005001095A1 Gene participating in growth promoting function of acetic acid bacterium and utilization of the same |
| 01/06/2005 | WO2005001093A1 Protein capable of deposition onto extracellular matrix |
| 01/06/2005 | WO2005001092A2 Compositions and methods for diagnosing and treating cancers |
| 01/06/2005 | WO2005001067A1 Animal bioreactors |
| 01/06/2005 | WO2005001062A2 Modified vectors for organelle transfection |
| 01/06/2005 | WO2005001061A2 Polynucleotides encoding novel adiponectin receptor variants |
| 01/06/2005 | WO2005001060A2 Novel calcium channel |
| 01/06/2005 | WO2005001057A2 Lactobacillus acidophilus nucleic acids encoding fructo-oligosaccharide utilization compounds and uses thereof |
| 01/06/2005 | WO2005001052A2 Modulation of apoptosis |
| 01/06/2005 | WO2005001050A2 Transcription factors |
| 01/06/2005 | WO2005001049A2 Compositions, splice variants and methods relating to ovarian specific genes and proteins |
| 01/06/2005 | WO2005001048A2 Preparation and application of anti-tumor bifunctional fusion proteins |
| 01/06/2005 | WO2005001044A2 Compositions related to pleiotrophin methods and uses thereof |
| 01/06/2005 | WO2005001036A2 Novel trichoderma genes |
| 01/06/2005 | WO2005001029A2 Ancestral viruses and vaccines |
| 01/06/2005 | WO2005001025A2 Immunoglobulin chimeric monomer-dimer hybrids |
| 01/06/2005 | WO2005000902A1 The dimer of chimeric recombinant binding domain-functional group fusion formed via disulfide-bond-bridge and the processes for producing the same |
| 01/06/2005 | WO2005000895A2 Vegf traps and therapeutic uses thereof |
| 01/06/2005 | WO2005000894A2 Binding molecules for the treatment of myeloid cell malignancies |
| 01/06/2005 | WO2005000893A2 Pharmaceutical composition comprising cyclic somatostin analogues |
| 01/06/2005 | WO2005000892A2 Glp-1 analog fusion plroteins |
| 01/06/2005 | WO2005000891A2 Thrombopoietin proteins with improved properties |
| 01/06/2005 | WO2005000890A1 Method for transplanting lymphohematopoietic cells into mammal |
| 01/06/2005 | WO2005000889A1 Immunogenic peptides for the treatment of prostate and breast cancer |
| 01/06/2005 | WO2005000888A2 NOVEL β-ACTIN AND RPS21 PROMOTERS AND USES THEREOF |
| 01/06/2005 | WO2005000887A1 Rasgap derived peptide for selectively killing cancer cells |
| 01/06/2005 | WO2005000886A2 T24 antigen for immunodiagnosis of taenia solium cysticercosis |
| 01/06/2005 | WO2005000885A1 Isolated photoprotein bolinopsin, and the use thereof |
| 01/06/2005 | WO2005000884A1 Poly-gamma-glutamic conjugates for eliciting immune responses directed against bacilli |
| 01/06/2005 | WO2005000883A1 Polypeptides having binding affinity for insulin |
| 01/06/2005 | WO2005000882A2 Dna fragments and proteins encoded by said dna isolated from bifidobacteria |
| 01/06/2005 | WO2005000881A2 Live attenuated viral vaccines for eastern equine encephalitis virus |
| 01/06/2005 | WO2005000877A2 Novel melanocortin receptor templates, peptides, and use thereof |
| 01/06/2005 | WO2005000876A2 Ring finger family proteins and uses related thereto |
| 01/06/2005 | WO2005000875A2 Compositions and methods comprising a ligand of chemerin receptor |
| 01/06/2005 | WO2005000872A2 Collagen mimics |
| 01/06/2005 | WO2005000871A2 Peptides antagonistic to an anti-angiogenic antibody and uses therefor |
| 01/06/2005 | WO2005000870A2 Isolated ny-eso-1 peptides which bind to hla class ii molecules and uses thereof |
| 01/06/2005 | WO2005000403A2 Compositions and methods for treating and preventing heart tissue degeneration, and uses thereof |
| 01/06/2005 | WO2005000359A2 Chemically-modified human growth hormone conjugates |
| 01/06/2005 | WO2005000336A2 The use of caldag-gefi inhibitors as antithrombotic agents |
| 01/06/2005 | WO2005000235A2 NUCLEIC ACID SEQUENCES ENCODING AND COMPOSITIONS COMPRISING IgE SIGNAL PEPTIDE AND/OR IL-15 AND METHODS FOR USING THE SAME |
| 01/06/2005 | WO2005000220A2 Method for treating cancer by vector-mediated delivery of one or more anti-angiogenic or pro-apoptotic genes |
| 01/06/2005 | WO2005000198A2 An intracellular estradiol binding protein, a polynucleotide encoding the same and cell lines overexpressing the same |
| 01/06/2005 | WO2005000192A2 Glycogen synthase kinase-3 inhibitors |
| 01/06/2005 | WO2005000099A2 BLOOD FACTOR DOMAINS (BFDs) |
| 01/06/2005 | WO2005000086A2 FRAGMENTS OF NKp44 AND NKp46 FOR TARGETING VIRAL-INFECTED AND TUMOR CELLS |
| 01/06/2005 | WO2004096845A3 Beta-amyloid inhibitors and use thereof |
| 01/06/2005 | WO2004092213B1 Gene expressed in prostate cancer, methods and use thereof |
| 01/06/2005 | WO2004090155A3 Methods for producing biological substances in enzyme-deficient mutants of aspergillus niger |
| 01/06/2005 | WO2004085683A3 Method for early carcinoma detection and a test kit for carrying our said method |
| 01/06/2005 | WO2004085478A3 Improved fc fusion proteins |
| 01/06/2005 | WO2004083865A3 Materials and methods for modulating cell motility |
| 01/06/2005 | WO2004082574A3 Diagnostics and therapeutics for diseases associated with dopamine receptor d5 (drd5) |
| 01/06/2005 | WO2004076474A3 Polyethylene glycol modified interferon compositions and methods of use thereof |
| 01/06/2005 | WO2004075635A3 Crystal structure of the ternary compelex of 14-3-3, fusicoccin and plasma membrane atpase and methods for designing new herbicides |
| 01/06/2005 | WO2004074312A3 Tryptophyllin peptides and uses thereof |
| 01/06/2005 | WO2004047863A3 Genetic products differentially expressed in tumors and the use thereof |
| 01/06/2005 | WO2004041999A3 No-apical meristem proteins, polynucleotides and methods of use for same |
| 01/06/2005 | WO2004041997A3 Immunotherapy regimens in hiv-infected patients |
| 01/06/2005 | WO2004027026A3 Improved methods for preparing highly active april ligand polypeptides |
| 01/06/2005 | WO2004026888A3 Toll-like receptor 9 (tlr9) from various mammalian species |
| 01/06/2005 | WO2003102165A3 IMMUNOGENIC HBc CHIMER PARTICLES STABILIZED WITH AN N-TERMINAL CYSTEINE |
| 01/06/2005 | WO2003097688A9 Muteins of placental growth factor type 1, preparation method and application thereof |
| 01/06/2005 | WO2003078631A9 Novel genes |
| 01/06/2005 | WO2003044040A9 Alpha-fetoprotein peptides and uses thereof |
| 01/06/2005 | WO2002074234A3 Method and composition for treatment of skeletal dysplasias |
| 01/06/2005 | WO2002055700A8 Human genes and gene expression products isolated from human prostate |
| 01/06/2005 | US20050005334 Herbicide tolerant cotton plants and methods for producing and identifying same peptide |
| 01/06/2005 | US20050005333 Isolated polynucleotide encoding a transcription factor; suppressing endogenous expression of chalcone synthase, leucoanthocyanidin dioxygenase and phenylalanine ammonia lyase |
| 01/06/2005 | US20050005317 Expression of zebrafish bone morphogenetic protein 4 |
| 01/06/2005 | US20050005316 Extracellular matrix signaling molecules |
| 01/06/2005 | US20050005313 Using magnetic resonance imaging to identify tagged tumor marker sequences; prepariing and using antisense agents as therapeutic tools in treatment of cell proliferative disorders; immunotherapy |
| 01/06/2005 | US20050005312 Propagation of human hepatocytes in non-human animals |